The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

Check out this year's top 5 pieces of sleep coverage that cover topics surveying the benefits of supplements, novel ...

For those who have tried unsuccessfully to use a CPAP machine to treat sleep apnea, the Inspire implant is a breakthrough ...

FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in ...

Wall Street saw gains as the S&P 500 rose 0.7% and the Nasdaq climbed 1%, driven by tech and communications stocks. Despite ...

Stocks closed higher on Wall Street at the start of a holiday-shortened week. The S&P 500 rose 0.7% Monday. Several big ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

Honda and Nissan merger talks stir Wall Street, as tech stocks like Nvidia and Broadcom provide market support. Meanwhile, ...

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” Dr. Sally Seymour ...

ABC News' Dr. Darien Sutton breaks down the FDA’s approval of the popular weight loss medication for the treatment of ...

In our fast-paced world, people tend to multitask, making it challenging to absorb information. Here's when to consult a ...